GSK (GSK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good ...

Leading vaccine makers are under investor scrutiny as Robert F. Kennedy Jr., a notable vaccine skeptic and President Donald Trump’s nominee to lead the Department of Health and Human Services (HHS), ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including sig ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

If approved, GSK's depemokimab will be the first ultra-long-acting biologic that requires only one dose every six months.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Press Release - With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia[1] classed as 'zero dose', having never received a routine vaccination, the Save the Children ...

The Quadram Institute has appointed Dr Linda Bradley as its first-ever Entrepreneur in Residence. The new role is designed to ...

The Bombay High Court emphasized that the statutory requirement for a pre-deposit could not be circumvented through a writ petition. The Court pointed out that the issue raised was not purely a legal ...

Every year, 21.5 million people are forcibly displaced by floods, droughts, wildfires, and storms. This number ...